Literature DB >> 21510735

HIV infection and pulmonary arterial hypertension.

Stefania Cicalini1, Pierangelo Chinello, Nicola Petrosillo.   

Abstract

Pulmonary arterial hypertension (PAH) is a rare but severe disease that results from chronic obstruction of small pulmonary arteries, leading to right ventricular failure and, ultimately, death. One established risk factor for the development of PAH is HIV infection. In comparison with the incidence of idiopathic PAH in the general population (1-2 per million), HIV-infected patients have a 2500-fold increased risk of developing PAH. The presence of PAH is an independent risk factor for mortality in patients with HIV infection, and in most cases death is causally related to PAH rather than to other complications of HIV infection. This article will focus on HIV-PAH with special considerations to epidemiology, pathogenesis, clinical presentation, diagnostic approach and available treatments.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21510735     DOI: 10.1586/ers.11.10

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  5 in total

1.  Enhanced autophagy in pulmonary endothelial cells on exposure to HIV-Tat and morphine: Role in HIV-related pulmonary arterial hypertension.

Authors:  Pranjali Dalvi; Himanshu Sharma; Mahendran Chinnappan; Miles Sanderson; Julie Allen; Ruoxi Zeng; Augustine Choi; Amy O'Brien-Ladner; Navneet K Dhillon
Journal:  Autophagy       Date:  2016-10-10       Impact factor: 16.016

2.  Physiologically-Based Pharmacokinetic Modeling of Macitentan: Prediction of Drug-Drug Interactions.

Authors:  Ruben de Kanter; Patricia N Sidharta; Stéphane Delahaye; Carmela Gnerre; Jerome Segrestaa; Stephan Buchmann; Christopher Kohl; Alexander Treiber
Journal:  Clin Pharmacokinet       Date:  2016-03       Impact factor: 6.447

3.  Pulmonary arterial hypertension related to human immunodeficiency virus infection: A case series.

Authors:  Inês Araújo; Cristina Enjuanes-Grau; Carmen Jimenez Lopez-Guarch; Dariusz Narankiewicz; Maria J Ruiz-Cano; Teresa Velazquez-Martin; Juan Delgado; Pilar Escribano
Journal:  World J Cardiol       Date:  2014-06-26

4.  Assessment of Pulmonary Arterial Hemodynamic and Vascular Changes by Pulmonary Pulse Transit Time in Patients with Human Immunodeficiency Virus Infection.

Authors:  Mehmet Akif Erdol; Burak Acar; Ahmet Goktug Ertem; Mustafa Karanfil; Çağrı Yayla; Koray Demırtas; Pelin Aladağ; Meliha Çağla Sönmezer; Esra Kaya Kiliç; Çiğdem Ataman Hatipoğlu; Fatma Sebnem Erdinc; Necla Tulek; Adnan Burak Akcay
Journal:  J Cardiovasc Echogr       Date:  2021-05-21

5.  Gene expression analysis of a murine model with pulmonary vascular remodeling compared to end-stage IPAH lungs.

Authors:  Kayoko Shimodaira; Yoichiro Okubo; Eri Ochiai; Haruo Nakayama; Harutaka Katano; Megumi Wakayama; Minoru Shinozaki; Takao Ishiwatari; Daisuke Sasai; Naobumi Tochigi; Tetsuo Nemoto; Tsutomu Saji; Katsuhiko Kamei; Kazutoshi Shibuya
Journal:  Respir Res       Date:  2012-11-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.